Preclinical studies have investigated KPV in cell and animal models, including research examining NF-κB and MAPK signaling, pro-inflammatory cytokine production, and experimental models of intestinal inflammation. Findings to date are predominantly preclinical and should be interpreted according to the experimental model, study design, and specific endpoints being measured.